Cargando…
Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Cardiology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475692/ https://www.ncbi.nlm.nih.gov/pubmed/37653697 http://dx.doi.org/10.4070/kcj.2023.0161 |
| _version_ | 1785100768986005504 |
|---|---|
| author | Park, Jae-Hyeong |
| author_facet | Park, Jae-Hyeong |
| author_sort | Park, Jae-Hyeong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10475692 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Korean Society of Cardiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104756922023-09-05 Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy? Park, Jae-Hyeong Korean Circ J Editorial The Korean Society of Cardiology 2023-07-21 /pmc/articles/PMC10475692/ /pubmed/37653697 http://dx.doi.org/10.4070/kcj.2023.0161 Text en Copyright © 2023. The Korean Society of Cardiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Park, Jae-Hyeong Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy? |
| title | Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy? |
| title_full | Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy? |
| title_fullStr | Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy? |
| title_full_unstemmed | Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy? |
| title_short | Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy? |
| title_sort | should we use renin-angiotensin-aldosterone system inhibitors routinely in patients with hypertrophic cardiomyopathy? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475692/ https://www.ncbi.nlm.nih.gov/pubmed/37653697 http://dx.doi.org/10.4070/kcj.2023.0161 |
| work_keys_str_mv | AT parkjaehyeong shouldweusereninangiotensinaldosteronesysteminhibitorsroutinelyinpatientswithhypertrophiccardiomyopathy |